uric acid has been researched along with tenofovir in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hanabusa, H; Kinai, E | 1 |
| Bogner, J; Claas, GJ; Goebel, FD; Jülg, B | 1 |
| Chong, WH; Collins, MT; Gara, N; Ghany, MG; Hoofnagle, JH; Jake Liang, T; Kleiner, DE; Zhao, X | 1 |
| Broderick, E; Hotta, MT; Wyatt, CM | 1 |
| Almeida, JR; Esberard, EB; Lopes, PF; Lugon, JR; Medeiros, T; Mendes, GF; Patricio, JA; Silva, AA | 1 |
| Fan, R; Jiang, Y; Liang, J; Liao, X; Wu, L; Yin, J; Yu, N; Zhang, Q; Zhao, S | 1 |
1 trial(s) available for uric acid and tenofovir
| Article | Year |
|---|---|
Metabolic and anthropometric changes one year after switching from didanosine/stavudine to tenofovir in HIV-infected patients.
Topics: Adenine; Adult; Aged; Anti-HIV Agents; Body Weight; CD4 Lymphocyte Count; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Didanosine; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Hemoglobins; HIV Infections; Humans; Lactic Acid; Male; Middle Aged; Organophosphonates; Phosphates; Skinfold Thickness; Stavudine; Tenofovir; Treatment Outcome; Triglycerides; Uric Acid; Viral Load | 2007 |
5 other study(ies) available for uric acid and tenofovir
| Article | Year |
|---|---|
Renal tubular toxicity associated with tenofovir assessed using urine-beta 2 microglobulin, percentage of tubular reabsorption of phosphate and alkaline phosphatase levels.
Topics: Absorption; Adenine; Adult; Alkaline Phosphatase; Antiretroviral Therapy, Highly Active; beta 2-Microglobulin; Creatinine; HIV Infections; HIV-1; Humans; Kidney Tubules; Middle Aged; Organophosphonates; Phosphates; Phosphorus; Reverse Transcriptase Inhibitors; Tenofovir; Uric Acid | 2005 |
Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B.
Topics: Adenine; Adult; Aged; Antiviral Agents; Biomarkers; Creatinine; Female; Glomerular Filtration Rate; Hepatitis B, Chronic; Humans; Kidney Tubules; Male; Middle Aged; Organophosphonates; Phosphates; Renal Insufficiency; Tenofovir; Time Factors; Uric Acid | 2012 |
Urine processing impacts uric acid level in HIV-infected adults: implications for diagnosing tenofovir-associated proximal tubulopathy.
Topics: Adenine; Adult; AIDS-Associated Nephropathy; Anti-HIV Agents; HIV Infections; Humans; Organophosphonates; Sensitivity and Specificity; Specimen Handling; Tenofovir; Time Factors; Uric Acid | 2013 |
Tenofovir monotherapy for hepatitis B after 1 year does not produce renal dysfunction, but is associated with hyperparathyroidism not related to vitamin D.
Topics: Adult; Albuminuria; Alkaline Phosphatase; Antiviral Agents; beta 2-Microglobulin; Creatinine; Cystatin C; Electrolytes; Female; Glomerular Filtration Rate; Hepatitis B; Humans; Hyperparathyroidism; Male; Middle Aged; Parathyroid Hormone; Renal Insufficiency; Serum Albumin; Tenofovir; Urea; Uric Acid; Vitamin D | 2016 |
Real-life impact of tenofovir disoproxil fumarate and entecavir therapy on lipid profile, glucose, and uric acid in chronic hepatitis B patients.
Topics: Antiviral Agents; Glucose; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lipids; Retrospective Studies; Tenofovir; Treatment Outcome; Uric Acid | 2022 |